Arca Biopharma | ABIO - Zahlungsmittel Und Äquivalente

Aktienkurs
41.56
Täglich Wechseln
2.65 6.81%
Monatlich
16.87%
Jährlich
236.25%
Q1 Prognose
37.74




Zahlungsmittel Und Äquivalente Veränderung Datum
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 9.13B 316M 2025-12
Arca Biopharma USD 46.93M 44.32M 2025-12
Biogen USD 3.01B 854.3M 2025-12
Brainstorm Cell Therapeutics USD 5K 819K 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Capricor Therapeutics USD 287.85M 268.34M 2025-12
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Cytokinetics USD 122.52M 102.95M 2025-12
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Grifols EUR 979.78M 334.84M 2024-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Myriad Genetics USD 149.6M 4.2M 2025-12
Otsuka Holdings JPY 411.11B 3.62B 2025-06
Pfizer USD 1.34B 295M 2025-09
United Therapeutics USD 1.56B 217M 2025-12